Arthritis Today - Autumn 2006
Issue 134
The appliance of science. Focus on Barts and The London
The Bone and Joint Research Unit at Barts and The London is leading the way in molecular and cell engineering in inflammatory types of arthritis - which could have a huge impact on the way these conditions are treated. Jane Tadman reports.
Younger and hipper
Metal-on-metal hip resurfacing is becoming increasingly popular among younger, more active people in need of a new hip. A new arc study aims to find out more about possible long-term effects.
Spotlight on science
Dr Mike Briggs and Dr M Kassim Javaid explain their work in an ongoing series of questions and answers with arc-funded researchers.
Hip tips - Preparing for a hip replacement
Retired paediatric physiotherapist Jean Ward, who recently had her second hip replaced, offers some good practical advice for others about to undergo hip replacement surgery.
Beyond anti-TNF therapy
As another new drug for severe rheumatoid arthritis is launched, Professor Jo Edwards of University College, London, who pioneered the use of rituximab (brand name MabThera) five years ago, explains how the drug works.
A new approach to pain
Professor Anthony Jones, head of the Pain Research Group at Hope Hospital, Salford, explains how he and his team are getting to grips with the causes of chronic pain.
